Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR - Summary - MDSpire

Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR

  • By

  • Dario Grassini

  • Karl-Patrik Kresoja

  • Jennifer von Stein

  • Vera Fortmeier

  • Christoph Pauschinger

  • Wolfgang Rottbauer

  • Mohammad Kassar

  • Bjoern Goebel

  • Paolo Denti

  • Paul Achouh

  • Tienush Rassaf

  • Manuel Barreiro-Perez

  • Peter Boekstegers

  • Andreas Rück

  • Monika Zdanyte

  • Marianna Adamo

  • Flavien Vincent

  • Philipp Schlegel

  • Sebastian Rosch

  • Mirjam G. Wild

  • Christian Besler

  • Stefan Toggweiler

  • Stephanie Brunner

  • Julia Grapsa

  • Tiffany Patterson

  • Holger Thiele

  • Tobias Kister

  • Giuseppe Tarantini

  • Giulia Masiero

  • Marco De Carlo

  • Cristina Giannini

  • Fabian Voss

  • Amin Polzin

  • Antonio Popolo Rubbio

  • Francesco Bedogni

  • Thorald Stolte

  • Thomas Nestelberger

  • Tomás Benito-González

  • Enrique Sánchez-Muñóz

  • Martijn Vrijkorte

  • Martin Swaans

  • Mathias H. Konstandin

  • Eric Van Belle

  • Marco Metra

  • Tobias Geisler

  • Rodrigo Estévez-Loureiro

  • Amir Abbas Mahabadi

  • Nicole Karam

  • Francesco Maisano

  • Philipp Lauten

  • Mirjam Kessler

  • Daniel Kalbacher

  • Volker Rudolph

  • Christos Iliadis

  • Philipp Lurz

  • Fabien Praz

  • Lukas Stolz

  • Jörg Hausleiter

  • May 18, 2026

  • 0 min

Share

Objective:

To investigate the impact of prior cardiac surgery (PCS) on procedural, functional, and long-term clinical outcomes in patients undergoing transcatheter edge-to-edge repair (T-TEER) for tricuspid regurgitation (TR), highlighting its clinical significance.

Key Findings:
  • 27.2% of patients had a history of PCS, with higher residual TR severity at discharge in the PCS group (20.7% vs. 15.1%), indicating a need for tailored management strategies.
  • TR reduction from baseline to discharge was lower in patients with PCS (69.0% vs. 75.0%), suggesting implications for procedural success.
  • PCS was independently associated with residual TR ≥ 3 + at discharge (OR 1.41), emphasizing the need for careful monitoring.
  • No significant difference in 30-day mortality between PCS and non-PCS groups (1.5% vs. 1.4%), indicating similar short-term safety.
Interpretation:

Patients with prior cardiac surgery undergoing T-TEER experience higher residual TR severity and lower procedural success compared to those without PCS, indicating a need for tailored management strategies and further research.

Limitations:
  • Retrospective design may introduce selection bias, and potential confounding factors should be considered.
  • Limited long-term follow-up data, suggesting the need for future studies to validate findings.
Conclusion:

Prior cardiac surgery negatively impacts procedural outcomes in T-TEER for TR, highlighting the importance of assessing surgical history in treatment planning and its implications for clinical practice.

Original Source(s)

Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR

  • by Dario Grassini, Karl-Patrik Kresoja, Jennifer von Stein, Vera Fortmeier, Christoph Pauschinger, Wolfgang Rottbauer, Mohammad Kassar, Bjoern Goebel, Paolo Denti, Paul Achouh, Tienush Rassaf, Manuel Barreiro-Perez, Peter Boekstegers, Andreas Rück, Monika Zdanyte, Marianna Adamo, Flavien Vincent, Philipp Schlegel, Sebastian Rosch, Mirjam G. Wild, Christian Besler, Stefan Toggweiler, Stephanie Brunner, Julia Grapsa, Tiffany Patterson, Holger Thiele, Tobias Kister, Giuseppe Tarantini, Giulia Masiero, Marco De Carlo, Cristina Giannini, Fabian Voss, Amin Polzin, Antonio Popolo Rubbio, Francesco Bedogni, Thorald Stolte, Thomas Nestelberger, Tomás Benito-González, Enrique Sánchez-Muñóz, Martijn Vrijkorte, Martin Swaans, Mathias H. Konstandin, Eric Van Belle, Marco Metra, Tobias Geisler, Rodrigo Estévez-Loureiro, Amir Abbas Mahabadi, Nicole Karam, Francesco Maisano, Philipp Lauten, Mirjam Kessler, Daniel Kalbacher, Volker Rudolph, Christos Iliadis, Philipp Lurz, Fabien Praz, Lukas Stolz, Jörg Hausleiter

  • May 18, 2026

Related Content

Case Report: Selective metal cell excision during open TAVR implantation preserves coronary access while maintaining valve integrity and function

The inflammatory fingerprint reveals immune cell populations associated with disease activity in cardiac sarcoidosis

Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis